| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund IDCW Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.31 |
| Equity |
100.21 |
| Trep |
0.10 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
41.89% |
| Top 10 Holdings |
61.92% |
| Top 25 Holdings |
94.55% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
62.34 |
| Healthcare |
37.87 |
| Cash |
-0.21 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.79 |
| PE Ratio |
38.72 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
14.87 |
| Lupin Limited |
9.47 |
| Fortis Health Care Ltd |
6.29 |
| Aurobindo Pharma Limited |
6.18 |
| Alkem Laboratories Limited |
5.08 |
| MANKIND PHARMA LIMITED |
4.78 |
| Laurus Labs Limited |
4.34 |
| Glenmark Pharmaceuticals Limited |
4.13 |
| IPCA Laboratories Limited |
3.70 |
| Biocon Limited |
3.08 |
| Krishna Inst of Medical Sciences Ltd. |
2.82 |
| Piramal Pharma Limited |
2.71 |
| Abbott India Limited |
2.57 |
| Syngene International Limited |
2.55 |
| Suven Pharmaceuticals Limited |
2.53 |
| J B Chemicals and Pharma Ltd |
2.38 |
| Gland Pharma Limited |
2.29 |
| Ajanta Pharma Limited |
2.14 |
| Aster DM Healthcare Limited |
2.03 |
| Dr Lal Path Labs Ltd |
2.01 |
| Natco Pharma Limited |
1.98 |
| Narayana Hrudalaya Ltd |
1.78 |
| Poly Medicure Limited |
1.67 |
| EQ- GLOBAL HEALTH LTD. |
1.63 |
| Glaxosmithkline Pharma Ltd |
1.54 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
